Sandy Lake Gold Inc. announces appointment of a new Chief Financial Officer
TORONTO, Nov. 22, 2018 (GLOBE NEWSWIRE) -- Sandy Lake Gold Inc. ("Sandy Lake Gold" or the "Company") (TSXV:SLAU) announces that Marie-Josée Audet has stepped down as the Chief Financial Officer of the Company and Yajian Wang has been appointed to the position of CFO.
The Company wishes to thank Ms. Audet for her services over the past three years.
Ms. Wang holds a degree of Master of Applied Science, enterprise systems engineering, from the University of Waterloo; and a degree of Master of Business Administration, Financial and Accounting from Wilfrid Laurier University; Waterloo, Canada. She has 25 years of financial and accounting experience.
CONTACT INFORMATION For further information contact: Sandy Lake Gold Inc. Patrick Sheridan, CEO Suite 1101? 141 Adelaide Street West Toronto, Ontario M5H 3L5 Telephone: (416) 628-5904
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Cybervation, an award-winning global technology and healthcare solutions company, proudly announces that its CEO, Purba Majumder, has been distinguished as one of the 2024 100 Women to KNOW Across America. This award from KNOW Women recognizes...
Blue Owl Capital Inc. ("Blue Owl") , a leading alternative asset manager, announced today the hiring of Alicia Gregory as a Managing Director based in Sydney.
Alicia brings over 25 years of investing experience with deep relationships and...
Zetrix Foundation and MY E.G. Services Berhad ("MYEG") signed a Memorandum of Understanding (MoU) with MaiCapital, a licensed virtual asset manager in Hong Kong, to collaborate on the launch of a virtual asset fund or Hong Kong virtual assets...
Grupo Elektra, S.A.B. de C.V. (BMV: ELEKTRA* Latibex: XEKT), Latin America's leading specialty retailer and financial services company, and the largest non-bank provider of...
O2Gold Inc. (NEX: OTGO.H) ("O2Gold" or the "Company") is pleased to announce that it has entered into a share exchange agreement dated March 21, 2024 (the "Agreement") with Quebec Aur Ltd., a private Ontario corporation, (the "Target") and its...
Hanmi Pharmaceutical (KOSPI: 128940, CEO: Jae-Hyun Park), a leading biopharma company in Korea that focuses on research areas such as oncology, obesity/metabolism, and rare diseases, announced it has entered into a Clinical Trial Collaboration and...
